chr4-3074876-C-CCAGCAGCAGCAG
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP3BP6_ModerateBS1BS2
The NM_001388492.1(HTT):c.99_110dupGCAGCAGCAGCA(p.Gln34_Gln37dup) variant causes a disruptive inframe insertion change. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.027 ( 75 hom., cov: 0)
Exomes 𝑓: 0.010 ( 164 hom. )
Consequence
HTT
NM_001388492.1 disruptive_inframe_insertion
NM_001388492.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.84
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAG is described in ClinVar as [Benign]. Clinvar id is 1690808.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0266 (3503/131854) while in subpopulation AMR AF= 0.0397 (532/13404). AF 95% confidence interval is 0.0369. There are 75 homozygotes in gnomad4. There are 1672 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 75 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTT | NM_001388492.1 | c.99_110dupGCAGCAGCAGCA | p.Gln34_Gln37dup | disruptive_inframe_insertion | 1/67 | ENST00000355072.11 | NP_001375421.1 | |
HTT | NM_002111.8 | c.99_110dupGCAGCAGCAGCA | p.Gln34_Gln37dup | disruptive_inframe_insertion | 1/67 | NP_002102.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTT | ENST00000355072.11 | c.99_110dupGCAGCAGCAGCA | p.Gln34_Gln37dup | disruptive_inframe_insertion | 1/67 | 1 | NM_001388492.1 | ENSP00000347184.5 |
Frequencies
GnomAD3 genomes AF: 0.0265 AC: 3497AN: 131756Hom.: 75 Cov.: 0
GnomAD3 genomes
AF:
AC:
3497
AN:
131756
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0103 AC: 12565AN: 1225544Hom.: 164 Cov.: 0 AF XY: 0.0111 AC XY: 6749AN XY: 608000
GnomAD4 exome
AF:
AC:
12565
AN:
1225544
Hom.:
Cov.:
0
AF XY:
AC XY:
6749
AN XY:
608000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0266 AC: 3503AN: 131854Hom.: 75 Cov.: 0 AF XY: 0.0264 AC XY: 1672AN XY: 63404
GnomAD4 genome
AF:
AC:
3503
AN:
131854
Hom.:
Cov.:
0
AF XY:
AC XY:
1672
AN XY:
63404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
See cases Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Feb 16, 2020 | ACMG classification criteria: BA1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at